Skip to main content
MedPathMedPath Home
Clinical Trials/NCT04623437
NCT04623437
Completed
Not Applicable

Comprehensive Antineoplastic Therapy Adverse Events Monitoring and Report

University Hospital "Sestre Milosrdnice"1 site in 1 country267 target enrollmentJuly 1, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPharmacovigilanceOncologyAntineoplastic Treatment

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pharmacovigilance
Sponsor
University Hospital "Sestre Milosrdnice"
Enrollment
267
Locations
1
Primary Endpoint
comparison of perspectives
Status
Completed
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

Study of pharmacovigilance in oncology. Monitoring and management of AEs during antineoplastic treatment.

Detailed Description

Monitoring and management of AE's during antineoplastic treatment. Comparison of AE's reported by patient with the ones recognised by the oncologist, and vice versa, during antineoplastic treatment.

Registry
clinicaltrials.gov
Start Date
July 1, 2017
End Date
September 5, 2017
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital "Sestre Milosrdnice"
Responsible Party
Principal Investigator
Principal Investigator

Robert Šeparović

PhD MD

University Hospital "Sestre Milosrdnice"

Eligibility Criteria

Inclusion Criteria

  • •all cancer patients receiving systemic antineoplastic treatment, ECOG 0-2

Exclusion Criteria

  • •age \<18, \>75; other active and severe comorbidities; no solid cancer; IUC patients

Outcomes

Primary Outcomes

comparison of perspectives

Time Frame: may 2016 until october 2016

comparison between patient's and oncologist's perspective on severity of AE's during antineoplastic treatment

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Not Applicable
Monitoring of Adverse Event for Anticancer Drugs Using Mobile HealthcareCancers
JPRN-UMIN000052672Hamamatsu University School of Medicine40
Recruiting
Not Applicable
Evaluation of Reporting of AdVerse Events Associated With AnTicAncer theRapy (AVATAR)Cancer
NCT04696250University Hospital, Caen5,000,000
Unknown
Not Applicable
Anticancer Vigilance Of Cardiac Events (AVOCETTE) in Metastatic Colorectal CancerColorectal Cancer Metastatic
NCT03923036University Hospital, Caen2,000
Not yet recruiting
Phase 3
Effect of Antineoplaston Therapy on the QT/QTc Interval In Subjects With Diffuse, Intrinsic, Brainstem GliomaBrain Stem Glioma
NCT02864888Burzynski Research Institute30
Completed
Not Applicable
Study Evaluating Pharmacovigilance Of Refacto AFHemophilia A
NCT00895037Pfizer101